A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2013
The purpose of the study is to evaluate dose response of JNJ-54781532 in participants with moderately to severely active ulcerative colitis (UC).
Epistemonikos ID: 0a040cfa2676364dab63fcd60f498a59567f2b63
First added on: Mar 23, 2022